$2.63 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 77 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Sell | AMGEN INC | $106,072,000 | -25.6% | 663,575 | -25.8% | 4.03% | -37.0% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS | $46,518,000 | +64.0% | 164,947 | -9.3% | 1.77% | +38.8% |
| PTCT | Sell | PTC THERAPEUTICS I | $45,829,000 | -22.0% | 753,141 | -33.7% | 1.74% | -34.0% |
| MNKKQ | Sell | MALLINCKRODT PLCshares | $43,488,000 | +9.6% | 343,370 | -14.3% | 1.65% | -7.2% |
| OMED | Sell | ONCOMED PHARMACEUTICALS | $39,536,000 | +13.7% | 1,533,578 | -4.0% | 1.50% | -3.8% |
| MDVN | Sell | MEDIVATION INC | $26,961,000 | -24.1% | 208,889 | -41.5% | 1.02% | -35.8% |
| XLRN | Sell | ACCELERON PHARMA | $22,805,000 | -18.0% | 599,184 | -16.1% | 0.87% | -30.6% |
| CLVS | Sell | CLOVIS ONCOLOGY | $18,495,000 | -22.0% | 249,152 | -41.2% | 0.70% | -34.0% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $15,247,000 | -16.2% | 30,191 | -12.3% | 0.58% | -29.1% |
| HTWR | Sell | HEARTWARE INTL INC | $13,500,000 | +9.1% | 153,815 | -8.7% | 0.51% | -7.6% |
| ADXS | Sell | ADVAXIS INC | $2,175,000 | +28.8% | 150,654 | -28.5% | 0.08% | +9.2% |
| TNDM | Sell | TANDEM DIABETES CA | $1,406,000 | -15.8% | 111,422 | -15.2% | 0.05% | -29.3% |
| QURE | Exit | UNIQURE N.V.shares | $0 | – | -94,101 | -100.0% | -0.06% | – |
| RNA | Exit | PROSENSA HLDGS | $0 | – | -111,432 | -100.0% | -0.09% | – |
| INGN | Exit | INOGEN INC | $0 | – | -206,734 | -100.0% | -0.29% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS | $0 | – | -708,585 | -100.0% | -0.31% | – |
| MDT | Exit | MEDTRONIC INC | $0 | – | -310,025 | -100.0% | -1.00% | – |
| AGN | Exit | ALLERGAN INC | $0 | – | -162,750 | -100.0% | -1.55% | – |
| P103PS | Exit | NPS PHARMACEUTICALS | $0 | – | -1,623,073 | -100.0% | -2.60% | – |
| REGN | Exit | REGENERON PHARMCEUTICALS | $0 | – | -185,685 | -100.0% | -3.42% | – |
| MYL | Exit | MYLAN INC | $0 | – | -1,519,368 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.